Guoxin Zhang

Oldham Council — United Kingdom

Neuroscience · Life Sciences

10h-index1.1kcitations48works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Circadian rhythm and melatonin(11), RNA Interference and Gene Delivery(11), Cancer, Lipids, and Metabolism(9), Cancer, Hypoxia, and Metabolism(7), RNA modifications and cancer(6)

Publications48 total

Dynamic Analysis of Arch Dam-Foundation Systems on Heterogeneous Soil
SSRN Electronic Journal·2026Open Access
AIM2 promotes the progression of HNSCC via STAT1 mediated transcription and IL-17/MAPK signaling
Cellular Signalling·2024· 7 cited
Retraction Notice to: A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells
Molecular Cell·2024
Table S2 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S1 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S2 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Data from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Data from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S4 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S1 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Supplementary Figures and Legends from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S3 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Supplementary Figures and Legends from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S4 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Table S3 from Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells
2023Open Access
Data from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
2023Open Access
Supplementary reagents from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
2023Open Access
Data from Glioma Stem Cell–Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling
2023Open Access
Supplementary figures and legends from Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock
2023Open Access
Supplementary Data from Glioma Stem Cell–Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Jeremy N. Rich(44), Briana C. Prager(38), Ryan C. Gimple(38), Leo J.Y. Kim(35), Zhixin Qiu(29), Deguan Lv(28), Zhen Dong(28), Qiulian Wu(28), Deobrat Dixit(27), Zhe Zhu(24), Lukas Chávez(22), Shruti Bhargava(22), Xiuxing Wang(20), Linjie Zhao(20), Stephen C. Mack(19), Jia Shen(18), Xiuxing Wang(17), Kailin Yang(16), Charles Spruck(15), Qiulian Wu(13)